TAT/TK dual-modified nanomicelles for celastrol delivery suppress lung cancer growth and pulmonary metastasis via NLRP3-driven pyroptosis
Authors:
- 8 June 2026
- journal article
- Published by Elsevier in Materials Science and Engineering: C
- Vol. 188, 215004
Abstract
No abstract availableKeywords
This publication has 44 references indexed in Scilit:
- Expression and prognosis of mPRα/PAQR7 in human cancers and validation in lung squamous cell carcinoma3 Biotech, 2025
- Orchestrated metal-coordinated carrier-free celastrol hydrogel intensifies T cell activation and regulates response to immune checkpoint blockade for synergistic chemo-immunotherapyBiomaterials, 2024
- SIRT6 Protects Against Lipopolysaccharide-Induced Inflammation in Human Pulmonary Lung Microvascular Endothelial CellsInflammation, 2023
- CircSETD3 mediates acquired resistance to gefitinib in non-small lung cancer cells by FXR1/ECT2 pathwayThe International Journal of Biochemistry & Cell Biology, 2022
- Tripterine and miR-184 show synergy to suppress breast cancer progressionBiochemical and Biophysical Research Communications, 2021
- Adverse drug reactions in older adults: a narrative review of the literatureEuropean Geriatric Medicine, 2021
- Structural Mechanism for GSDMD Targeting by Autoprocessed Caspases in PyroptosisCell, 2020
- Exploiting the dynamics of the EPR effect and strategies to improve the therapeutic effects of nanomedicines by using EPR effect enhancersAdvanced Drug Delivery Reviews, 2020
- ASC Speck Formation as a Readout for Inflammasome Activation2013
- Cell-penetrating macromolecules: Direct penetration of amphipathic phospholipid polymers across plasma membrane of living cellsBiomaterials, 2010